Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sonneborn is a global leader in the manufacture and supply of high-purity specialty hydrocarbons, including white oils, petrolatums, and microcrystalline waxes. The company serves the pharmaceutical, personal care, and food industries, providing USP and BP grade products that function as excipients, bases for ointments, and lubricants. With a history spanning over a century, Sonneborn operates major manufacturing facilities in North America and Europe. In 2019, the company was acquired by HollyFrontier (now HF Sinclair), integrating its specialty products into a broader energy and lubricants portfolio. Their pharmaceutical offerings are critical components in topical medications, capsules, and various healthcare applications requiring high-purity mineral-based ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sonneborn.